Article
p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma
1 Jul 1998
Abstract excerpt
The product of the p16/INK4a/CDKN2/MTS1 tumor-suppressor gene acts as a negative cell cycle regulator by inhibiting G1 cyclin-dependent kinases that phosphorylate the retinoblastoma protein. p16 is inactivated in a wide range of human malignancies, including familial melanoma. However, its expression and function in sporadic melanoma has not been extensively investigated. We studied p16 expression in 62 archival...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
